TY - JOUR AU - Connock, M. AU - Juarez-Garcia, A. AU - Jowett, S. AU - Frew, E. AU - Liu, Z. AU - Taylor, R. J. PY - 2007 DA - 2007// TI - Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation JO - Health Technol Assess VL - 11 ID - Connock2007 ER - TY - STD TI - United Nations World Drug Report. Recent statistics and trend analysis of illicit drug market. 2012. https://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_Chapter1.pdf. Accessed 23 Jun 2015. UR - https://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_Chapter1.pdf ID - ref2 ER - TY - JOUR AU - Ross, J. AU - Teesson, M. AU - Darke, S. AU - Lynskey, M. AU - Ali, R. AU - Ritter, A. PY - 2005 DA - 2005// TI - The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS) JO - Drug Alcohol Rev VL - 24 UR - https://doi.org/10.1080/09595230500286039 DO - 10.1080/09595230500286039 ID - Ross2005 ER - TY - STD TI - World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. 2009. http://www.who.int/substance_abuse/publications/opioid_dependence_guidelines.pdf. Accessed 28 May 2015. UR - http://www.who.int/substance_abuse/publications/opioid_dependence_guidelines.pdf ID - ref4 ER - TY - STD TI - Doran C. Economic evaluation of interventions for illicit opioid dependence: a review of evidence. 2007. http://www.who.int/substance_abuse/activities/economic_evaluation_interventions.pdf. Accessed 18 Nov 2015. UR - http://www.who.int/substance_abuse/activities/economic_evaluation_interventions.pdf ID - ref5 ER - TY - STD TI - BMA Board of Science. Drugs of dependence (full report). Chapter 3—the burden of illicit drug use. 2013. http://bma.org.uk/news-views-analysis/in-depth-drugs-of-dependence/full-report. Accessed 26 Jun 2015. UR - http://bma.org.uk/news-views-analysis/in-depth-drugs-of-dependence/full-report ID - ref6 ER - TY - JOUR AU - Barnard, M. AU - McKeganey, N. PY - 2004 DA - 2004// TI - The impact of parental problem drug use on children: what is the problem and what can be done to help? JO - Addiction VL - 99 UR - https://doi.org/10.1111/j.1360-0443.2003.00664.x DO - 10.1111/j.1360-0443.2003.00664.x ID - Barnard2004 ER - TY - JOUR AU - Soyka, M. PY - 2015 DA - 2015// TI - New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone JO - Subst Abuse Rehabil VL - 6 UR - https://doi.org/10.2147/SAR.S45585 DO - 10.2147/SAR.S45585 ID - Soyka2015 ER - TY - STD TI - Institute for Clinical and Economic Review. Management of patients with opioid dependence: a review of clinical, delivery system, and policy options 2014. https://icer-review.org/wpcontent/uploads/2016/01/CEPAC-Opioid-Dependence-Final-Report-For-Posting-July-211. Accessed 28 May 2015. UR - https://icer-review.org/wpcontent/uploads/2016/01/CEPAC-Opioid-Dependence-Final-Report-For-Posting-July-211 ID - ref9 ER - TY - STD TI - University of Glasgow, Department of General Practice. Critical appraisal checklist for economic evaluations. 2015. http://www.gla.ac.uk/media/media_64048_en.pdf Accessed 3 Jun 2015. UR - http://www.gla.ac.uk/media/media_64048_en.pdf ID - ref10 ER - TY - JOUR AU - Barnett, P. G. PY - 1999 DA - 1999// TI - The cost-effectiveness of methadone maintenance as a health care intervention JO - Addiction VL - 94 UR - https://doi.org/10.1046/j.1360-0443.1999.9444793.x DO - 10.1046/j.1360-0443.1999.9444793.x ID - Barnett1999 ER - TY - JOUR AU - Barnett, P. G. AU - Zaric, G. S. AU - Brandeau, M. L. PY - 2001 DA - 2001// TI - The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States JO - Addiction VL - 96 UR - https://doi.org/10.1046/j.1360-0443.2001.96912676.x DO - 10.1046/j.1360-0443.2001.96912676.x ID - Barnett2001 ER - TY - JOUR AU - Masson, C. L. AU - Barnett, P. G. AU - Sees, K. L. AU - Delucchi, K. L. AU - Rosen, A. AU - Wong, W. PY - 2004 DA - 2004// TI - Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification JO - Addiction VL - 99 UR - https://doi.org/10.1111/j.1360-0443.2004.00728.x DO - 10.1111/j.1360-0443.2004.00728.x ID - Masson2004 ER - TY - JOUR AU - Miller, C. L. AU - Schechter, M. T. AU - Wood, E. AU - Spittal, P. M. AU - Li, K. AU - Laliberte, N. PY - 2004 DA - 2004// TI - The potential health and economic impact of implementing a medically prescribed heroin program among Canadian injection drug users JO - Int J Drug Policy VL - 15 UR - https://doi.org/10.1016/j.drugpo.2004.04.001 DO - 10.1016/j.drugpo.2004.04.001 ID - Miller2004 ER - TY - JOUR AU - Negrin, M. A. AU - Vazquez-Polo, F. J. PY - 2006 DA - 2006// TI - Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane JO - Health Econ VL - 15 UR - https://doi.org/10.1002/hec.1056 DO - 10.1002/hec.1056 ID - Negrin2006 ER - TY - JOUR AU - Schackman, B. R. AU - Leff, J. A. AU - Polsky, D. AU - Moore, B. A. AU - Fiellin, D. A. PY - 2012 DA - 2012// TI - Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care JO - J Gen Intern Med VL - 27 UR - https://doi.org/10.1007/s11606-011-1962-8 DO - 10.1007/s11606-011-1962-8 ID - Schackman2012 ER - TY - JOUR AU - Sheerin, I. G. AU - Green, F. T. AU - Sellman, J. D. PY - 2004 DA - 2004// TI - What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand? JO - Drug Alcohol Rev VL - 23 UR - https://doi.org/10.1080/09595230412331289419 DO - 10.1080/09595230412331289419 ID - Sheerin2004 ER - TY - JOUR AU - Stephen, J. H. AU - Halpern, C. H. AU - Barrios, C. J. AU - Balmuri, U. AU - Pisapia, J. M. AU - Wolf, J. A. PY - 2012 DA - 2012// TI - Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis JO - Addiction VL - 107 UR - https://doi.org/10.1111/j.1360-0443.2011.03656.x DO - 10.1111/j.1360-0443.2011.03656.x ID - Stephen2012 ER - TY - JOUR AU - Tran, B. X. AU - Ohinmaa, A. AU - Duong, A. T. AU - Nguyen, L. T. AU - Vu, P. X. AU - Mills, S. PY - 2012 DA - 2012// TI - The cost-effectiveness and budget impact of Vietnam’s methadone maintenance treatment programme in HIV prevention and treatment among injection drug users JO - Glob Public Health VL - 7 UR - https://doi.org/10.1080/17441692.2012.736259 DO - 10.1080/17441692.2012.736259 ID - Tran2012 ER - TY - JOUR AU - Zaric, G. S. AU - Barnett, P. G. AU - Brandeau, M. L. PY - 2000 DA - 2000// TI - HIV transmission and the cost-effectiveness of methadone maintenance JO - Am J Public Health VL - 90 UR - https://doi.org/10.2105/AJPH.90.7.1100 DO - 10.2105/AJPH.90.7.1100 ID - Zaric2000 ER - TY - JOUR AU - Zaric, G. S. AU - Brandeau, M. L. AU - Barnett, P. G. PY - 2000 DA - 2000// TI - Methadone maintenance and HIV prevention: a cost-effectiveness analysis JO - Manag Sci VL - 46 UR - https://doi.org/10.1287/mnsc.46.8.1013.12025 DO - 10.1287/mnsc.46.8.1013.12025 ID - Zaric2000 ER - TY - JOUR AU - Zarkin, G. A. AU - Dunlap, L. J. AU - Hicks, K. A. AU - Mamo, D. PY - 2005 DA - 2005// TI - Benefits and costs of methadone treatment: results from a lifetime simulation model JO - Health Econ VL - 14 UR - https://doi.org/10.1002/hec.999 DO - 10.1002/hec.999 ID - Zarkin2005 ER - TY - JOUR AU - Adi, Y. AU - Juarez-Garcia, A. AU - Wang, D. AU - Jowett, S. AU - Frew, E. AU - Day, E. PY - 2007 DA - 2007// TI - Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation JO - Health Technol Assess VL - 11 UR - https://doi.org/10.3310/hta11060 DO - 10.3310/hta11060 ID - Adi2007 ER - TY - STD TI - Schering-Plough. Manufacturer’s submission. Cited in Connock et al. Health Technol Assess. 2007;11:1–171, iii–iv. ID - ref24 ER - TY - STD TI - Scottish Medicines Consortium. Buprenorphine/naloxone 2 mg/0.5 mg, 8/2 mg sublingual tablet (Suboxone). No. 355/07. 2007. https://www.scottishmedicines.org.uk/files/buprenorphine_naloxone_sublingual_tablet__Suboxone__355-07_.pdf. Accessed 3 Jun 2015. UR - https://www.scottishmedicines.org.uk/files/buprenorphine_naloxone_sublingual_tablet__Suboxone__355-07_.pdf ID - ref25 ER - TY - JOUR AU - Clay, E. AU - Kharitonova, E. AU - Ruby, J. AU - Aballea, S. AU - Zah, V. PY - 2014 DA - 2014// TI - Medicaid population budget impact analysis of buprenorphine/naloxone film and tablet formulation JO - Value Health VL - 17 UR - https://doi.org/10.1016/j.jval.2014.03.1244 DO - 10.1016/j.jval.2014.03.1244 ID - Clay2014 ER - TY - JOUR AU - Clay, E. AU - Khemiri, A. AU - Ruby, J. AU - Aballea, S. AU - Zah, V. PY - 2014 DA - 2014// TI - A studies-based private insurance budget impact analysis of buprenorphine/naloxone film and tablet formulations JO - Value Health VL - 17 ID - Clay2014 ER - TY - JOUR AU - Fowler, J. AU - Emerson, J. AU - Allen, A. AU - Dilley, S. AU - Gideonse, N. AU - Rieckmann, T. PY - 2013 DA - 2013// TI - Buprenorphine vs methadone for maintenance of opioid addiction during pregnancy: a cost-effectiveness analysis JO - Am J Obstet Gynecol VL - 208 UR - https://doi.org/10.1016/j.ajog.2012.10.289 DO - 10.1016/j.ajog.2012.10.289 ID - Fowler2013 ER - TY - STD TI - College voor zorgverzekeringen, Diemen. Guidelines for pharmacoeconomic research, updated version. 2006. http://www.ispor.org/PEguidelines/source/HTAGuidelinesNLupdated2006.pdf. Accessed 27 Jul 2015. UR - http://www.ispor.org/PEguidelines/source/HTAGuidelinesNLupdated2006.pdf ID - ref29 ER - TY - STD TI - National Institute for Health and Care Excellence. Process and methods guides: guide to the methods of technology appraisal. 2013. http://www.nice.org.uk/article/PMG9/chapter/Foreword. Accessed 4 Mar 2015. UR - http://www.nice.org.uk/article/PMG9/chapter/Foreword ID - ref30 ER - TY - STD TI - Norwegian Medicines Agency (NOMA). Guidelines on how to conduct pharmacoeconomic analyses. 2012. http://www.ispor.org/PEguidelines/source/Norwegian_guidelines2012.pdf. Accessed 27 Jul 2015. UR - http://www.ispor.org/PEguidelines/source/Norwegian_guidelines2012.pdf ID - ref31 ER - TY - STD TI - Pharmaceutical Benefits Board, Sweden. General guidelines for economic evaluations from the Pharmaceutical Benefits Board (LFNAR 2003:2). 2003. http://www.ispor.org/PEguidelines/source/Guidelines_in_Sweden.pdf. Accessed 27 Jul 2015. UR - http://www.ispor.org/PEguidelines/source/Guidelines_in_Sweden.pdf ID - ref32 ER - TY - STD TI - Pharmaceutical Benefits Advisory Committee (PBAC). Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.3). 2008. http://www.pbac.pbs.gov.au/content/information/archived-versions/pbac-guidelines-v4.3-2008.pdf. Accessed 21 Jul 2015. UR - http://www.pbac.pbs.gov.au/content/information/archived-versions/pbac-guidelines-v4.3-2008.pdf ID - ref33 ER - TY - STD TI - Centers for Disease Control. HIV cost-effectiveness. 2013. http://www.cdc.gov/hiv/prevention/ongoing/costeffectiveness/. Accessed 18 Nov 2015. UR - http://www.cdc.gov/hiv/prevention/ongoing/costeffectiveness/ ID - ref34 ER -